Physician

Michael Borg Limberg, M.D.

According to 2025 Medicare claims, Michael Limberg, M.D. (NPI: 1063569655) practices ophthalmology in the San Luis Obispo-Paso Robles, CA market, with the plurality of this provider's patient population coming from San Luis Obispo, CA. This provider's primary affiliated billing organization is LIMBERG EYE SURGERY A MEDICAL CORPORATION (NPI: 1952459265; TIN: 770418808) and primary practice location at 93401-2821.

Limberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 838 traditional Medicare patients, billed 9,339 HCPCS/CPT codes, and received $594,854 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 930 prescription claims across 271 beneficiaries totaling $64,516 in drug costs, led by Rhopressa (Netarsudil Mesylate). Open Payments data shows 28 records totaling $1,413. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $90,678 and ending at $64,516. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$424K$847K2015 Medicare payment: $720,443 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $847,074 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $800,411 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $780,117 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $831,635 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $675,201 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $682,205 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $567,908 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $575,345 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $594,854 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201597911,765$720,443
201696612,760$847,074
201799520,762$800,411
201899014,582$780,117
201993914,349$831,635
202089412,819$675,201
202188911,070$682,205
20228248,594$567,908
20238449,359$575,345
20248389,339$594,854

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$45K$91K2015 Drug cost: $90,678 (USD; Tot_Drug_Cst)2016 Drug cost: $75,226 (USD; Tot_Drug_Cst)2017 Drug cost: $59,236 (USD; Tot_Drug_Cst)2018 Drug cost: $62,433 (USD; Tot_Drug_Cst)2019 Drug cost: $57,422 (USD; Tot_Drug_Cst)2020 Drug cost: $60,099 (USD; Tot_Drug_Cst)2021 Drug cost: $57,388 (USD; Tot_Drug_Cst)2022 Drug cost: $60,291 (USD; Tot_Drug_Cst)2023 Drug cost: $80,000 (USD; Tot_Drug_Cst)2024 Drug cost: $64,516 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015223817$90,678
2016191678$75,226
2017191672$59,236
2018218751$62,433
2019191541$57,422
2020185555$60,099
2021187554$57,388
2022199554$60,291
2023228801$80,000
2024271930$64,516

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system630858$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more425872$63
92083Exam of visual field with extended testing400493$42
92134Imaging of retina355480$28
92133Imaging of optic nerve6111,134$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RhopressaNetarsudil Mesylate181,005$10,033
Tobramycin-DexamethasoneTobramycin/Dexamethasone1884,165$6,528
CyclosporineCyclosporine12855$5,298
TravoprostTravoprost181,045$3,593
Loteprednol EtabonateLoteprednol Etabonate19596$2,992

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$1,413ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Borg Limberg, M.D.?

Tedicare shows public-source Medicare data for Michael Borg Limberg, M.D. (NPI 1063569655), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Borg Limberg, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Borg Limberg, M.D.?

Michael Borg Limberg, M.D. is linked to LIMBERG EYE SURGERY A MEDICAL CORPORATION (billing NPI 1952459265) in the available physician profile data.

Does Michael Borg Limberg, M.D. have Open Payments data?

Michael Borg Limberg, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.